News
U.S. Food and Drug Administration Approves Kaleo’s EVZIO for the Emergency Treatment of Opioid Overdose
RICHMOND, Va., April 3, 2014 /PRNewswire/ — Kaleo (formerly Intelliject) today announced that the U.S. Food and Drug Administration (FDA) has approved EVZIO™ (naloxone hydrochloride injection) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is the first and only naloxone auto-injector intended to be available for immediate administration by family members or caregivers for suspected opioid overdose in settings where opioids may be present…
Click here for the full story.